CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 12  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1057
LYS 10.0180
GLU 20.0486
LEU 30.0239
ARG 40.0131
CYS 50.0145
GLN 60.0153
CYS 70.0087
ILE 80.1057
LYS 90.0363
THR 100.0069
TYR 110.0090
SER 120.0074
LYS 130.0072
PRO 140.0061
PHE 150.0039
HIS 160.0062
PRO 170.0042
LYS 180.0113
PHE 190.0084
ILE 200.0082
LYS 210.0122
GLU 220.0099
LEU 230.0095
ARG 240.0096
VAL 250.0105
ILE 260.0107
GLU 270.0203
SER 280.0306
GLY 290.0499
PRO 300.0705
HIS 310.0237
CYS 320.0261
ALA 330.0453
ASN 340.0292
THR 350.0178
GLU 360.0132
ILE 370.0118
ILE 380.0118
VAL 390.0104
LYS 400.0128
LEU 410.0115
SER 420.0159
ASP 430.0203
GLY 440.0209
ARG 450.0187
GLU 460.0155
LEU 470.0108
CYS 480.0130
LEU 490.0107
ASP 500.0095
PRO 510.0101
LYS 520.0112
GLU 530.0110
ASN 540.0143
TRP 550.0104
VAL 560.0099
GLN 570.0127
ARG 580.0096
VAL 590.0060
VAL 600.0088
GLU 610.0080
LYS 620.0024
PHE 630.0064
LEU 640.0132
LYS 650.0138
ARG 660.0197
ALA 670.0258
GLU 680.0362
ASN 690.0474

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.